The oncology pharmacy residency is a specialized program consisting of 12 months of individualized training designed to provide a diverse clinical experience which focuses on direct patient care in a wide variety of settings.
PGY2 pharmacy residency programs build on Doctor of Pharmacy (Pharm.D.) education and PGY1 pharmacy residency programs to contribute to the development of clinical pharmacists in specialized areas of practice. PGY2 residencies provide residents with opportunities to function independently as practitioners by conceptualizing and integrating accumulated experience and knowledge and incorporating both into the provision of patient care that improves medication therapy. Residents who successfully complete an accredited PGY2 pharmacy residency should possess competencies that qualify them for clinical pharmacist and/or faculty positions and position them to be eligible for attainment of board certification in the specialized practice area (when board certification for the practice area exists).
Geisinger Cancer Service Line
The Geisinger Cancer Service Line provides integral and personal care by experienced hematologists and medical oncologists at multiple care delivery sites throughout Pennsylvania. The cancer programs at both Geisinger Medical Center and Geisinger Wyoming Valley (GWV) are accredited by the American College of Surgeons Commission on Cancer as well as achieving QOPI® (Quality Oncology Practice Initiative) certification from the American Society of Clinical Oncology (ASCO). The bone marrow transplant program is accredited by the Foundation for Accreditation of Cellular Therapy (FACT). The Geisinger Cancer Institute is also an NCI-supported Community Clinical Oncology Research Program (NCORP) which is the core of the oncology clinical trials program providing a direct link to the NCI. Geisinger Cancer Institute currently has more than 90 clinical trials open and available for many different cancer, precancerous conditions and supportive care.